New hypertension drug shows promise in Mid-Stage trial
NCT ID NCT07373613
First seen Feb 01, 2026 · Last updated May 12, 2026 · Updated 12 times
Summary
This study tests five different doses of a new medicine called BR1400 in 330 adults with high blood pressure (essential hypertension). The goal is to see how well each dose lowers blood pressure and if it is safe. Participants will take the medicine for 8 weeks, and their blood pressure will be measured regularly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hanyang University Hospital
Soeul, South Korea
Contact
Conditions
Explore the condition pages connected to this study.